Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma.

Autor: Benjamini O; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv. ohad.benjamini@sheba.health.gov.il., Fried S; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shouval R; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Flynn JR; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York., Beyar-Katz O; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa., Leslie LA; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey., Zucherman T; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa., Yerushalmi R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shem-Tov N; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Palomba ML; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Danylesko I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Sdayoor I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Malka H; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa., Itzhaki O; Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Hashomer., Suh H; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey., Devlin SM; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York., Marcus R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Dahi PB; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Jacoby E; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv, Israel; Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Chaim Sheba Medical Center, Hashomer., Shah GL; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York., Sauter CS; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH., Ip A; John Theurer Cancer Center, Hackensack, University Medical Center, Hackensack New Jersey, United States; Hackensack Meridian School of Medicine, Nutley, NJ., Perales MA; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Shimoni A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv., Scordo M; Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine Weill Cornell Medical College, New York., Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Hashomer, Israel; School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv.

Publikováno v: Haematologica [Haematologica] 2024 Nov 01; Vol. 109 (11), pp. 3566-3577. Date of Electronic Publication: 2024 Nov 01.

Liver stiffness measurements predict Sinusoidal Obstructive Syndrome after hematopoietic stem cell transplantation.

Autor: Davidov Y; Liver Diseases Center, Sheba Medical Center, Tel-Hashomer, Israel. y.davidov@gmail.com.; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. y.davidov@gmail.com., Shem-Tov N; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; The Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel-Hashomer, Israel., Yerushalmi R; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; The Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel-Hashomer, Israel., Hod T; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; Renal Transplant Center and Nephrology department, Sheba Medical Center, Tel-Hashomer, Israel., Ben-Ari Z; Liver Diseases Center, Sheba Medical Center, Tel-Hashomer, Israel.; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel., Nagler A; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; The Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel-Hashomer, Israel., Shimoni A; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; The Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel-Hashomer, Israel., Danylesko I; Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.; The Division of Hematology and Bone Marrow Transplantation, Sheba Medical Center, Tel-Hashomer, Israel.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Aug; Vol. 59 (8), pp. 1070-1075. Date of Electronic Publication: 2024 Apr 24.

Point-of-care anti-CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory follicular lymphoma.

Autor: Fried S; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel., Shkury E; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel., Itzhaki O; Ella Lemelbaum Institute for Immuno Oncology, Chaim Sheba Medical Center, Tel Hashomer, Israel., Sdayoor I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel., Yerushalmi R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel., Shem-Tov N; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel., Danylesko I; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel., Jacoby E; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.; Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, Israel., Shouval R; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.; Adult BMT Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Kedmi M; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.; The Mina and Everard Goodman faculty of life sciences, Bar Ilan University, Ramat Gan, Israel., Marcus R; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel., Nagler A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel., Shimoni A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel., Avigdor A; Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2023 Dec; Vol. 64 (12), pp. 1956-1963. Date of Electronic Publication: 2023 Aug 11.

High lactate dehydrogenase at time of admission for allogeneic hematopoietic transplantation associates to poor survival in acute myeloid leukemia and non-Hodgkin lymphoma.

Autor: Geva M; Hematology Division and BMT, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Tel Aviv-Yafo, Israel. mikageva@gmail.com., Pryce A; Centre for Haematology, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London, UK., Shouval R; Hematology Division and BMT, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Tel Aviv-Yafo, Israel., Fein JA; Hematology Division and BMT, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Tel Aviv-Yafo, Israel., Danylesko I; Hematology Division and BMT, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Tel Aviv-Yafo, Israel., Shem-Tov N; Hematology Division and BMT, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Tel Aviv-Yafo, Israel., Yerushalmi R; Hematology Division and BMT, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Tel Aviv-Yafo, Israel., Shimoni A; Hematology Division and BMT, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Tel Aviv-Yafo, Israel., Szydlo R; Centre for Haematology, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London, UK., Pavlu J; Centre for Haematology, Faculty of Medicine, Hammersmith Hospital, Imperial College London, London, UK., Nagler A; Hematology Division and BMT, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv University, Tel Aviv-Yafo, Israel.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2021 Nov; Vol. 56 (11), pp. 2690-2696. Date of Electronic Publication: 2021 Jun 29.

Second hematopoietic stem cell transplantation as salvage therapy for relapsed acute myeloid leukemia/myelodysplastic syndromes after a first transplantation.

Autor: Yerushalmi Y; The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University and Sackler School of Medicine, Tel-Aviv., Shem-Tov N; The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University and Sackler School of Medicine, Tel-Aviv., Danylesko I; The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University and Sackler School of Medicine, Tel-Aviv., Canaani J; The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University and Sackler School of Medicine, Tel-Aviv., Avigdor A; The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University and Sackler School of Medicine, Tel-Aviv., Yerushalmi R; The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University and Sackler School of Medicine, Tel-Aviv., Nagler A; The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University and Sackler School of Medicine, Tel-Aviv., Shimoni A; The Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Tel-Aviv University and Sackler School of Medicine, Tel-Aviv. avichai.shimoni@sheba.health.gov.il.

Publikováno v: Haematologica [Haematologica] 2023 Jul 01; Vol. 108 (7), pp. 1782-1792. Date of Electronic Publication: 2023 Jul 01.